Streptococcus pneumoniae capsular polysaccharides — Drug Target

All drugs that target Streptococcus pneumoniae capsular polysaccharides — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Polysaccharide vaccine · Conjugate vaccine · Pneumococcal conjugate vaccine

Marketed (1)

• PPV Vaccine · Fakultas Kedokteran Universitas Indonesia · Polysaccharide vaccine · Immunology / Infectious Disease
  PPV vaccine stimulates the immune system to produce antibodies against pneumococcal polysaccharide antigens, providing protection against Streptococcus pneumoniae infection.

Phase 3 pipeline (2)

• Pneumococcal Conjugated Vaccine · Sanofi Pasteur, a Sanofi Company · Conjugate vaccine · Immunology / Infectious Disease
  A conjugated vaccine that stimulates the immune system to produce antibodies against pneumococcal polysaccharide antigens by linking them to a protein carrier.
• Pneumococcal vaccine GSK1024850A · GlaxoSmithKline · Pneumococcal conjugate vaccine · Immunology
  This pneumococcal conjugate vaccine stimulates the immune system to produce antibodies against multiple serotypes of Streptococcus pneumoniae bacteria.